Figure 2 | Scientific Reports

Figure 2

From: RETRACTED ARTICLE: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Figure 2

Comparing alpha diversity (phylogenetic diversity [Faith’s PD]) in stool samples before (week 0), after (week 2) and at follow up (week 8) for a 2-week rifaximin course versus no treatment. ***P < 0.001 (UNIANOVA, baseline values at week 0 is corrected for values at week −14 [baseline 2]).

Back to article page